Satellite Healthcare   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: San Jose CA United States (1973)

Organization Overview

First Clinical Trial
2003
NCT00571259
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Satellite Healthcare | Satellite Healthcare, Inc.

Active Ingredients

Drugs in Phase 4 Trials (4)

ergocalciferol (drisdol) (1 trial)

gentamicin (garamycin) (1 trial)

heparin (liquaemin) (1 trial)

sodium citrate (1 trial)

Drugs in Phase 2 Trials (2)

calcitriol (rocaltrol) (1 trial)

vitamin d3 (1 trial)

Drugs in Other Trials (1)

minocycline (minocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacteremia (Phase 4)

Calcinosis (Phase 2)

Kidney Failure, Chronic (Phase 4)

Vascular Calcification (Phase 2)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7